These two get grouped together as "magic mushrooms," and that grouping is wrong in a way that matters. Psilocybin mushrooms and Amanita muscaria — the red-and-white-spotted one — contain different compounds, act on different brain systems, produce different effects, and carry very different risks. One of them is genuinely poisonous.
Key Takeaways
- They are not the same class of substance — psilocybin acts on serotonin, Amanita on glutamate and GABA
- Psilocybin produces classic psychedelic effects; Amanita produces sedation and delirium
- Amanita muscaria is genuinely toxic — poisoning has been reported at doses under one cap
- Amanita products sold commercially are unregulated, and testing has found undisclosed substances in them
The Quick Answer
Psilocybin mushrooms contain psilocybin, which the body converts into psilocin — the compound that activates serotonin receptors and produces the perceptual and mood changes associated with psychedelics [1]. Amanita muscaria contains no psilocybin at all. Its active compounds are ibotenic acid and muscimol, which work on entirely different systems and produce a sedative, dream-like, sometimes delirium-type state rather than a psychedelic one [2].
If you want the finer distinction between psilocybin and psilocin specifically, that's covered in our guide to psilocybin vs. psilocin.
Completely Different Chemistry
The mechanisms genuinely have nothing in common. Ibotenic acid acts on the glutamate/NMDA system, producing an excitatory effect, and then decarboxylates into muscimol, which activates GABA-A receptors — the same broad system alcohol and benzodiazepines act on, producing sedation and amnesia-like effects [2]. Psilocin, by contrast, is serotonergic. Calling both "magic mushrooms" collapses two unrelated pharmacologies into one phrase.
Side-by-Side Comparison
| Psilocybin mushrooms | Amanita muscaria | |
|---|---|---|
| Active compound | Psilocybin → converts to psilocin | Ibotenic acid → converts to muscimol |
| Brain target | Serotonin receptors (primarily 5-HT2A) | Glutamate/NMDA (ibotenic acid) and GABA-A (muscimol) |
| Typical effects | Visual and perceptual changes, altered mood and thinking | Sedation, delirium, dream-like states — not classically psychedelic |
| Physical toxicity | Low physical toxicity | Genuinely toxic — poisoning reported at doses under one cap |
| Appearance | Typically small, brownish, often bruising blue | Distinctive bright red cap with white spots |
| Federal legal status | Schedule I controlled substance | Not federally scheduled — but see the caveats below |
Amanita Toxicity: The Real Risk
This is the part most comparisons underplay. Amanita muscaria is genuinely toxic. Poisoning has been documented at roughly 30–60 mg of ibotenic acid or about 15 mg of muscimol — which can be less than a single cap, depending on the specimen. Reported effects include delirium, drowsiness, and in severe poisonings, seizures and coma. Most people recover within about 24 hours with medical care, but severe cases and fatalities have been reported [2].
There's a second, newer risk worth knowing: commercially sold Amanita products are unregulated. A CDC report documented Schedule I substances found in mushroom "nootropic" gummies marketed as containing Amanita — meaning the label may not reflect the contents [4]. The FDA has also stated that muscimol and related Amanita constituents are not approved food additives [3].
Legal Status
Psilocybin is a Schedule I controlled substance federally. Amanita muscaria's active compounds are not currently federally scheduled, which is why Amanita products appear for sale where psilocybin ones don't. That gap causes a common and dangerous misreading: "not scheduled" is not "safe," "tested," or "regulated." As the toxicity section above shows, the unscheduled one is the one with the higher physical poisoning risk. State laws also vary and are changing, so verify current rules where you are.
When Mushroom Use Becomes a Problem
Most people reading this are simply curious, and that's fine. But if you landed here because use has started to worry you or someone else, it's worth naming what that usually looks like: leaning on it to manage anxiety, depression, or trauma; lingering anxiety after a difficult experience; or psychedelics being one part of broader substance use.
To be straightforward about scope: psychedelic use on its own usually isn't admitted as a standalone diagnosis. Where treatment genuinely helps is that far more common combination — substance use alongside an underlying mental health condition — which is what our dual-diagnosis programs treat together. If other substances are involved and stopping has been physically rough, medical detox may be the starting point. And if you're worried about someone else, our Families & Loved Ones team can help you think through how to raise it.
Suspected mushroom poisoning is a medical emergency. If someone is confused, drowsy and hard to rouse, seizing, or unresponsive after eating any mushroom, call 911 or Poison Control at 1-800-222-1222 — and bring a sample of the mushroom if you safely can. If this brings up thoughts of suicide or self-harm, call or text 988, the Suicide & Crisis Lifeline.
FAQs
- What’s the difference between psilocybin and Amanita muscaria?
- They’re entirely different substances that happen to both be mushrooms. Psilocybin mushrooms act on serotonin receptors and produce classic psychedelic effects; Amanita muscaria contains ibotenic acid and muscimol, which act on glutamate and GABA systems and produce sedation and delirium instead. They aren’t interchangeable, and Amanita carries real poisoning risk.
- Is Amanita muscaria a psychedelic?
- Not in the way psilocybin is. Its effects come from muscimol acting on GABA receptors, which produces sedative, dream-like, and sometimes delirium-type states rather than the serotonergic perceptual changes people associate with psychedelics.
- Is Amanita muscaria poisonous?
- Yes, it can be. Poisoning has been reported at doses of roughly 30–60 mg of ibotenic acid or 15 mg of muscimol — less than a single cap in some cases. Reported effects include delirium, drowsiness, and in severe poisonings, seizures and coma. Most people recover within about 24 hours with medical care, but it is not a harmless mushroom.
- Is Amanita muscaria legal?
- Its active compounds are not currently federally scheduled in the U.S., unlike psilocybin, which is Schedule I. But "not scheduled" is not the same as "safe" or "regulated" — the FDA has stated that muscimol and related Amanita constituents are not approved food additives, and state laws vary. Legal status is also changing, so verify current rules for your location.
- Are Amanita gummies safe?
- Products sold as Amanita gummies are unregulated, and testing has found real problems. A CDC report documented Schedule I substances turning up in mushroom "nootropic" gummies marketed as containing Amanita — meaning what’s on the label may not be what’s inside. There’s no reliable way to know what you’re taking.
- Is psilocybin addictive?
- It doesn’t typically produce physical dependence the way alcohol or opioids do, and tolerance builds quickly enough to limit frequent use. That doesn’t make it risk-free — psychological reliance can develop, and difficult experiences can have lasting mental health effects, particularly for people already vulnerable.
- Can mushroom use cause lasting mental health problems?
- It can. Distressing experiences can leave lingering anxiety, and for people with a personal or family history of psychosis or bipolar disorder, psychedelics may precipitate or worsen symptoms. Where someone is using to manage anxiety, depression, or trauma, that underlying condition is usually the more important thing to address.
- Can you get help for psychedelic misuse?
- Yes. Psychedelic use on its own usually isn’t treated as a standalone diagnosis, but when it’s happening alongside other substance use or an underlying mental health condition, that combination is very treatable — and it’s how this most often shows up. You can verify insurance coverage in a few minutes.
Sources
- National Institute on Drug Abuse (NIDA). Psilocybin (Magic Mushrooms).
- PMC, National Library of Medicine (NIH). Acute Amanita muscaria Toxicity: A Literature Review and Two Case Reports.
- U.S. Food & Drug Administration (FDA). Scientific Memorandum: Amanita muscaria.
- Centers for Disease Control and Prevention (CDC), MMWR. Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms.
This article is for informational purposes only and is not a substitute for professional medical advice. It is not guidance on identifying, foraging, preparing, or using any mushroom — misidentification of wild mushrooms can be fatal.
Written by
Executive Director
Dominic Perry is a Licensed Clinical Social Worker (LCSW), Licensed Clinical Alcohol and Drug Counselor (LCADC), Master Addiction Counselor (MAC), and DOT Substance Abuse Professional (SAP) with approximately eight years of experience in behavioral health and substance use treatment. Dominic began his work with Virtue as a therapist at the Corbett residential facility before progressing into leadership, and now serves as Executive Director of Virtue Recovery Center – Outpatient in Las Vegas. He earned his Bachelor of Social Work from UNLV and his Master of Social Work from the University of Nevada Reno.
Read Full Bio →
